Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04401215 · ClinicalTrials.gov registry record · NA
Technologically-Augmented Referrals to Mitigate Addiction Consequences
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04401215: Completed NA study, sponsored by Washington State University.
NCT04401215 is a NA study that has completed, run by Washington State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04401215, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The implementation of screening and intervention for substance use disorders, such as Screening Brief Intervention Referral to Treatment (SBIRT), in the primary care setting has faced several challenges. In the past, physicians have cited barriers such as lack of time, lack of access to treatment, and lack of financial resources. To overcome some of the barriers to screening and prevention of substance use disorders, many researchers have begun to explore novel approaches using web-based and mobile technology. While the quality of evidence is often inconsistent, there is promising research to show that interventions utilizing web-based or mobile technology for alcohol and other substance abuse can be effective. Features such as tailored feedback have shown to be more effective than similar programs without feedback, and interventions that combine self-administered therapy in conjunction with therapist-direction interventions show greater reductions in addictive behavior. In this project, the investigators proposed to enhance the Screening Brief Intervention Referral to Treatment (SBIRT) with a digital tool that aims to save physician time and improve patient adherence to treatment goals, through extensive use of shared decision making, patient self-monitoring and goal tracking, and real-time tailored patient feedback and text follow-up for patients. Increase the screening and referral of those patients at risk for substance use disorder (SUD) thereby increasing the number of patients receiving higher level substance use treatment. A total of 500 patients will be screened and randomized into two groups. 250 in the Technology Augmented Treatment group (intervention group) and 250 in the control group. The Washington State University research team, lead by Dr. McPherson, will screen and recruit subjects at CHAS Valley Clinic in Spokane, WA. Subjects in both groups will be followed up for 30 days. At the initial study enrollment visit, the intervention group will be
Primary Outcome
The investigators estimate that SBIRT intervention (Glass et al 2015) could result in 10% to 30% of patients receiving specialty care. The investigators computed power using the following assumptions: * Control arm with 20% participants receiving specialty care. * Intervention arm with 35% participants receiving specialty care. * Same number of participants in control and intervention. A sample of 197 participants in each of arms will be sufficiently powered to detect such differences between
Interventions
- BEHAVIORAL Technology Augmented Treatment for Screening, Brief Intervention, Referral, and Treatment (SBIRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
What the finished NCT04401215 record still lists
NCT04401215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Technology Augmented Treatment for Screening, Brief Intervention, Referral, and Treatment (SBIRT) is the first listed.
NCT04401215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04401215 about?
NCT04401215 is a clinical study titled "Technologically-Augmented Referrals to Mitigate Addiction Consequences". The implementation of screening and intervention for substance use disorders, such as Screening Brief Intervention Referral to Treatment (SBIRT), in the primary care setting has faced several challenges. In the past, physicians have cited barriers such as lack of time, lack of access to treatment, a...
What is the current status of trial NCT04401215?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-09-23. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT04401215?
The interventions under investigation include: Technology Augmented Treatment for Screening, Brief Intervention, Referral, and Treatment (SBIRT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04401215?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04401215's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI